NL193245B - Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat. - Google Patents

Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat.

Info

Publication number
NL193245B
NL193245B NL8420137A NL8420137A NL193245B NL 193245 B NL193245 B NL 193245B NL 8420137 A NL8420137 A NL 8420137A NL 8420137 A NL8420137 A NL 8420137A NL 193245 B NL193245 B NL 193245B
Authority
NL
Netherlands
Prior art keywords
compound
dihydroxyvitamin
pharmaceutical composition
regulating action
calcium metabolism
Prior art date
Application number
NL8420137A
Other languages
English (en)
Other versions
NL8420137A (nl
NL193245C (nl
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of NL8420137A publication Critical patent/NL8420137A/nl
Publication of NL193245B publication Critical patent/NL193245B/nl
Application granted granted Critical
Publication of NL193245C publication Critical patent/NL193245C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NL8420137A 1983-05-09 1984-05-09 Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat. NL193245C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49286383A 1983-05-09 1983-05-09
US49286383 1983-05-09
US60732784A 1984-05-04 1984-05-04
US60732784 1984-05-04

Publications (3)

Publication Number Publication Date
NL8420137A NL8420137A (nl) 1985-04-01
NL193245B true NL193245B (nl) 1998-12-01
NL193245C NL193245C (nl) 1999-04-02

Family

ID=27050897

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8420137A NL193245C (nl) 1983-05-09 1984-05-09 Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat.

Country Status (7)

Country Link
JP (3) JPH0610188B2 (nl)
AU (1) AU568549B2 (nl)
CH (1) CH665834A5 (nl)
DE (4) DE3448412C2 (nl)
DK (3) DK171397B1 (nl)
NL (1) NL193245C (nl)
WO (1) WO1984004527A1 (nl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0197949A1 (en) * 1984-10-04 1986-10-22 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
KR910004337B1 (ko) * 1985-01-17 1991-06-26 위스콘신 알럼니 리서치 화운데이션 비타민 d 유도체 및 이를 함유하는 약제
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
CA1341408C (en) * 1988-08-02 2002-12-10 Charles W. Bishop Method for treating and preventing loss of bone mass
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
IN171426B (nl) * 1990-02-14 1992-10-10 Wisconsin Alumni Res Found
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JP3722832B2 (ja) * 1992-06-22 2005-11-30 ルーナー、コーポレーション 経口用１α−ヒドロキシプレビタミンＤ
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
NZ336924A (en) 1997-02-13 2001-06-29 Bone Care Int Inc Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
US20090233889A1 (en) 2008-03-12 2009-09-17 Uttam Saha Stabilized 1,25-dihydroxyvitamin d2 and method of making same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same

Also Published As

Publication number Publication date
DK172733B1 (da) 1999-06-21
DK183291D0 (da) 1991-11-07
JPH02288829A (ja) 1990-11-28
DE3448360C2 (nl) 1991-10-02
NL8420137A (nl) 1985-04-01
DE3490215T (de) 1985-05-15
AU3011584A (en) 1984-12-04
DE3448412C2 (nl) 1991-12-12
JPH0339505B2 (nl) 1991-06-14
AU568549B2 (en) 1988-01-07
JPH0651624B2 (ja) 1994-07-06
NL193245C (nl) 1999-04-02
CH665834A5 (de) 1988-06-15
DE3490215C2 (nl) 1991-07-25
WO1984004527A1 (en) 1984-11-22
DK8685D0 (da) 1985-01-08
DK184588D0 (da) 1988-04-06
JPH02288873A (ja) 1990-11-28
DK184588A (da) 1988-04-06
DK183291A (da) 1991-11-07
DK171397B1 (da) 1996-10-14
JPH0610188B2 (ja) 1994-02-09
DK8685A (da) 1985-01-08
DK172567B1 (da) 1999-01-18
JPH02288854A (ja) 1990-11-28

Similar Documents

Publication Publication Date Title
NL193245B (nl) Aan 1Ó,25-dihydroxyvitamine D2 verwante verbinding en farmaceutisch preparaat met een het calciummetabolisme regulerende werking dat een dergelijke verbinding bevat.
NL193457B (nl) Benzoheterocyclische verbindingen en farmaceutisch preparaat dat een dergelijke verbinding bevat.
DE3486255D1 (de) Pharmazeutische Zusammensetzungen.
DK143689A (da) Pakningsmateriale
DE69204159D1 (de) Verpackungsanlage.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
DE68914176D1 (de) Photopolymerisierbare Zusammensetzung.
DE3786361D1 (de) Verpackungsmaterial.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
NL188501C (nl) Harsachtige samenstelling voor een tandheelkundige toepassing.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DE68913531D1 (de) Kalziumhypochloritzusammensetzung.
FI893643A (fi) Farmaceutiska kompositioner.
DE3866574D1 (de) Verpackungsmaterial.
ATE126666T1 (de) Imazalil enthaltende synergistische zusammensetzungen.
DE3482215D1 (de) Photopolymerisierbare zusammensetzung.
DE68919102D1 (de) Photopolymerisierbare Zusammensetzung.
NL193191B (nl) 1,3-Oxazolidine-2-on-derivaten en farmaceutisch preparaat dat een dergelijke verbinding bevat.
IT1212889B (it) Composizioni pesticide contenenti un agente fotostabilizzante
DE3483900D1 (de) Pharmazeutische zusammensetzungen.
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
DE68909863D1 (de) Verpacken.
NL192573B (nl) 2,5-Digesubstitueerde tetrahydrofuran- of tetrahydrothiofeenverbindingen met werking tegen de bloedplaatjesactiverende factor en farmaceutisch preparaat dat deze verbindingen bevat.
IT8820562A0 (it) Composizione di calcestruzzo contenente un additivo superfluidificante.
DE58905106D1 (de) Neue 1,2-dithiol-3-thion-s-oxid-verbindungen enthaltende arzneimittel.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20031201